PALATIN TECHNOLOGIES INC (PTN)
About PALATIN TECHNOLOGIES INC
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$17.3M
- Total assets
- $3.3M
- Market cap
- $25.2M
- Gross margin
- 97.8%
- Operating margin
- -501.0%
- Net margin
- -662.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $4.5M
- Cost of revenue
- $97.6K
- Gross profit
- $4.4M
- Operating expenses
- $27.0M
- Operating income
- -$22.5M
- Income tax
- $0
- Net income
- -$29.7M
- EPS (basic)
- $-2.02
Balance sheet
- Total assets
- $10.7M
- Current assets
- $9.8M
- Total liabilities
- $10.9M
- Current liabilities
- $9.7M
- Shareholders’ equity
- -$111.5K
Cash flow
- Operating cash flow
- -$31.5M
- Investing cash flow
- $12.5M
- Financing cash flow
- $20.5M
- Net cash flow
- $1.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $25.2M
- Shares outstanding
- 3.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 4, 1993
Palatin Technologies Inc (PTN) Stock Price
- Reported a net loss of $17.3M in FY2025.
- Revenue grew 3706% from FY2020 to FY2024.
- Gross margin of 97.8%, net margin -662.3%.
- Trading 72% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PALATIN TECHNOLOGIES INC.
Write a review
News about PALATIN TECHNOLOGIES INC
News & sentiment via Polygon.io
Palatin Technologies Inc: frequently asked questions
Is Palatin Technologies Inc an American company?
Palatin Technologies Inc is a US-based company headquartered in Cranbury, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Palatin Technologies Inc headquartered?
Palatin Technologies Inc is headquartered in Cranbury, New Jersey, United States.
Is Palatin Technologies Inc publicly traded?
Yes — Palatin Technologies Inc is a publicly traded company. Its stock trades under the ticker symbol PTN on the NYSE.
What does Palatin Technologies Inc do?
Palatin Technologies Inc is an American Pharmaceuticals company in the Health & Beauty sector.
